Immunomodulatory ionophore copolymers, T150R1 and T130R2, induce corticotropin from anterior pituitary cells.
T150R1 is a synthetic copolymer with Na+ ionophore activity. We demonstrated previously that T150R1, when injected into mice, produces rapid thymic involution with depletion of cortical thymocytes. Elevated serum ACTH and corticosterone levels, as well as abrogation of the effects of T150R1 on the thymus by adrenalectomy and hypophysectomy, suggested a pituitary-mediated mechanism. In this work, we investigated the ability of T150R1, and of the related ionophore copolymer T130R2, to stimulate ACTH in vitro from the mouse anterior pituitary cell line AtT-20. Copolymer-induced ACTH release was dose-, time-, and temperature-dependent. Hormone induction peaked at 30 degrees C for T150R1 and 37 degrees C for T130R2. The temperature dependence of ACTH release paralleled that of ionophore activity measured in red blood cells, providing evidence that the ability to induce ACTH is related to the ionophore property of the copolymers. Peak ionophore activity and hormonal release occurred at the temperatures when the copolymers form partially soluble complexes which interact optimally with cell membranes. Cotreatment with exogenous phospholipase C inhibited the effects of T150R1, which suggests that the enzyme either blocks the insertion of T150R1 into the cell membrane or that the phospholipase C-induced increase in intracellular calcium inhibits the ionophore activity of T150R1. These data support an ionophore mechanism for copolymer-induced ACTH release in which changes in the physicochemical structure of the copolymers may affect their interaction with cell membranes. The data also suggest that direct stimulation of pituitary ACTH accounts for at least some of the in vivo immunomodulatory effects of T150R1.
Houssami
R
R
Department of Pathology, Emory University, Atlanta, Georgia 30322.
Check
I J
IJ
D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000818:Animals; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D005029:Ethylenediamines / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007476:Ionophores / Q000494:pharmacology*; D007700:Kinetics; D051379:Mice; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism*; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000494:pharmacology*; D011188:Potassium / Q000097:blood; D012995:Solubility; D013696:Temperature; D010738:Type C Phospholipases / Q000494:pharmacology
D005029:Ethylenediamines; D007476:Ionophores; C075213:T130R2; C012571:tetronic 701; D011092:Polyethylene Glycols; D000324:Adrenocorticotropic Hormone; D010738:Type C Phospholipases; D011188:Potassium